These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 34650688)

  • 1. Integrative Analysis of Methylation and Copy Number Variations of Prostate Adenocarcinoma Based on Weighted Gene Co-expression Network Analysis.
    Hou Y; Hu J; Zhou L; Liu L; Chen K; Yang X
    Front Oncol; 2021; 11():647253. PubMed ID: 33869043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the predictive value of angiogenesis-related genes for prognosis and immunotherapy response in prostate adenocarcinoma using machine learning and experimental approaches.
    Wang Y; He J; Zhao Q; Bo J; Zhou Y; Sun H; Ding B; Ren M
    Front Immunol; 2024; 15():1416914. PubMed ID: 38817605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Machine Learning Methods to Study Colorectal Cancer Tumor Micro-Environment and Its Biomarkers.
    Wei W; Li Y; Huang T
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1QL1/CTRP14 Is Largely Dispensable for Atherosclerosis Formation in Apolipoprotein-E-Deficient Mice.
    Guan H; Shi T; Liu M; Wang X; Guo F
    J Cardiovasc Dev Dis; 2022 Oct; 9(10):. PubMed ID: 36286293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of senescence-related molecular subtypes and key genes for prostate cancer.
    Feng DC; Zhu WZ; Shi X; Xiong Q; You J; Wei Q; Yang L
    Asian J Androl; 2023; 25(2):223-229. PubMed ID: 36124532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAM107A Inactivation Associated with Promoter Methylation Affects Prostate Cancer Progression through the FAK/PI3K/AKT Pathway.
    Ke S; Liu Z; Wang Q; Zhai G; Shao H; Yu X; Guo J
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good or not good: Role of miR-18a in cancer biology.
    Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
    Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of FAM107A as a potential biomarker and therapeutic target for prostate carcinoma.
    Ma YF; Li GD; Sun X; Li XX; Gao Y; Gao C; Cao KX; Yang GW; Yu MW; Wang XM
    Am J Transl Res; 2021; 13(9):10163-10177. PubMed ID: 34650688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications.
    Ma Z; Cheng X; Yue T; Shangguan X; Xin Z; Zhang W; Pan J; Wang Q; Xue W
    Cancer Med; 2021 Aug; 10(15):5358-5374. PubMed ID: 34128342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma.
    Zhang D; Zhang M; Zhang Q; Zhao Z; Nie Y
    Med Sci Monit; 2020 Jul; 26():e924543. PubMed ID: 32735556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gleason Score-related MT1L as biomarker for prognosis in prostate adenocarcinoma and contribute to tumor progression in vitro.
    Liu L; Li Y; Tang S; Yang B; Zhang Q; Xiao R; Hou X; Liu C; Ma L
    Int J Biol Markers; 2023 Jun; 38(2):114-123. PubMed ID: 37192745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration.
    Piao S; Zheng L; Zheng H; Zhou M; Feng Q; Zhou S; Ke M; Yang H; Wang X
    J Immunol Res; 2022; 2022():2922832. PubMed ID: 35707002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nur77 Serves as a Potential Prognostic Biomarker That Correlates with Immune Infiltration and May Act as a Good Target for Prostate adenocarcinoma.
    Hu QY; Liu J; Zhang XK; Yang WT; Tao YT; Chen C; Qian YH; Tang JS; Yao XS; Xu YH; Wang JH
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommended Definitions of Aggressive Prostate Cancer for Etiologic Epidemiologic Research.
    Hurwitz LM; Agalliu I; Albanes D; Barry KH; Berndt SI; Cai Q; Chen C; Cheng I; Genkinger JM; Giles GG; Huang J; Joshu CE; Key TJ; Knutsen S; Koutros S; Langseth H; Li SX; MacInnis RJ; Markt SC; Penney KL; Perez-Cornago A; Rohan TE; Smith-Warner SA; Stampfer MJ; Stopsack KH; Tangen CM; Travis RC; Weinstein SJ; Lang PhD W; Jacobs EJ; Mucci LA; Platz EA; Cook MB;
    J Natl Cancer Inst; 2021 Jun; 113(6):727-734. PubMed ID: 33010161
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.